| Peter Lang Steinberg, MD | |
|
330 Brookline Ave, Bidmc Division Of Urology, Rabb 440, Boston, MA 02215-5400 | |
| (617) 667-3739 | |
| Not Available |
| Full Name | Peter Lang Steinberg |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 21 Years |
| Location | 330 Brookline Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033227426 | NPI | - | NPPES |
| 30209571 | Medicaid | NH | |
| 435745199 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | RT1178 (New Hampshire) | Secondary |
| 208800000X | Urology | 018468 (Maine) | Secondary |
| 208800000X | Urology | 253715 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc | 4486567104 | 1344 |
News Archive
Early-stage breast cancer patients of Japanese descent that are treated with a lumpectomy and radiation therapy are more likely to be cured of their cancer than women of other ancestries, according to a new study published in the May 2005 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
When a parent takes an infant to the Children's Health Center in San Francisco for a routine checkup, a pediatrician will check the baby's vitals and ask how the child is doing at home.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
The Wall Street Journal: "Proponents of the new health-care law say it does attempt to address the physician shortage. The law offers sweeteners to encourage more people to enter medical professions, and a 10% Medicare pay boost for primary-care doctors. … Meanwhile, a number of new medical schools have opened around the country recently."
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
› Verified 8 days ago
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720037385 PECOS PAC ID: 4486567104 Enrollment ID: O20031203000426 |
News Archive
Early-stage breast cancer patients of Japanese descent that are treated with a lumpectomy and radiation therapy are more likely to be cured of their cancer than women of other ancestries, according to a new study published in the May 2005 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
When a parent takes an infant to the Children's Health Center in San Francisco for a routine checkup, a pediatrician will check the baby's vitals and ask how the child is doing at home.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
The Wall Street Journal: "Proponents of the new health-care law say it does attempt to address the physician shortage. The law offers sweeteners to encourage more people to enter medical professions, and a 10% Medicare pay boost for primary-care doctors. … Meanwhile, a number of new medical schools have opened around the country recently."
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
› Verified 8 days ago
| Entity Name | Beth Israel Deaconess Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
Early-stage breast cancer patients of Japanese descent that are treated with a lumpectomy and radiation therapy are more likely to be cured of their cancer than women of other ancestries, according to a new study published in the May 2005 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
When a parent takes an infant to the Children's Health Center in San Francisco for a routine checkup, a pediatrician will check the baby's vitals and ask how the child is doing at home.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
The Wall Street Journal: "Proponents of the new health-care law say it does attempt to address the physician shortage. The law offers sweeteners to encourage more people to enter medical professions, and a 10% Medicare pay boost for primary-care doctors. … Meanwhile, a number of new medical schools have opened around the country recently."
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Lang Steinberg, MD 330 Brookline Ave, Bidmc Division Of Urology, Rabb 440, Boston, MA 02215-5400 Ph: (617) 667-3739 | Peter Lang Steinberg, MD 330 Brookline Ave, Bidmc Division Of Urology, Rabb 440, Boston, MA 02215-5400 Ph: (617) 667-3739 |
News Archive
Early-stage breast cancer patients of Japanese descent that are treated with a lumpectomy and radiation therapy are more likely to be cured of their cancer than women of other ancestries, according to a new study published in the May 2005 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
When a parent takes an infant to the Children's Health Center in San Francisco for a routine checkup, a pediatrician will check the baby's vitals and ask how the child is doing at home.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
The Wall Street Journal: "Proponents of the new health-care law say it does attempt to address the physician shortage. The law offers sweeteners to encourage more people to enter medical professions, and a 10% Medicare pay boost for primary-care doctors. … Meanwhile, a number of new medical schools have opened around the country recently."
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
› Verified 8 days ago
Brian Howard Eisner, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-3512 | |
Catherine Gu, MD Urology Medicare: Not Enrolled in Medicare Practice Location: Bwh 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Dr. Dianne E Sacco, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Dept Of Urology, Boston, MA 02114 Phone: 617-726-3760 Fax: 617-726-6131 | |
Richard N Yu, M.D, PH.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 300 Longwood Ave, Department Of Urology, Hu-390, Boston, MA 02115 Phone: 617-355-7796 | |
Dr. Quoc-dien Trinh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 45 Francis St, Division Of Urology, Boston, MA 02115 Phone: 617-525-7350 | |
Dr. Melise A Keays, MD Urology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |